Navigation Links
Cephalon Announces Issuance of Patent for AMRIX
Date:6/17/2008

n the United States include: TREANDA(R) (bendamustine hydrochloride) for injection, AMRIX, PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products; interpretation of clinical results; manufacturing development and capabilities; market prospects for its products, including AMRIX; sales and earnings guidance; and other statements regarding matters that are not historical facts, including statements regarding the AMRIX patent. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
2. Cephalon Notified of Generic Fentanyl Buccal Tablet Filing
3. Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
4. Cephalon Quarterly Conference Call Invitation
5. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
6. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
7. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
8. Cephalon General Counsel John E. Osborn to Resign Position
9. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... ... global failure analysis market is expected to reach $7,147.0 million by 2020, at a ... at the highest CAGR of 8.46%; its growth is expected to be driven by ... for root cause analysis of failure. The market based on the geographic regions has ...
(Date:7/3/2015)... 3, 2015 Forskere ... 2015 på  http://www.openinnovationinscience.at om efteruddannelsesprogrammet "Lab ... sted i Wien .  ... internationale forskere og videnskabsmænd foretaget af Ludwig ... udfordringer for sundhedsvidenskaben manglen på incitamenter til ...
(Date:7/2/2015)... , July 2, 2015 Amici ... Bio-tech procurement company Amici Procurement has chosen Microsoft Cloud ... it move to Office 365.      (Logo: ... small to medium-sized companies in the bio-tech sector with ... of the purchasing cycle to help them obtain best ...
(Date:7/1/2015)... and PARIS , ... AgBiome, and Genective, key developer of biotech crops, ... discovery of new generations of insect control traits. ... control to counter the realities of advancing insect ... aligning AgBiome,s unique insect control technology with Genective,s ...
Breaking Biology Technology:Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3Biotech Procurement Company Moves to Office 365 with iomart 2AgBiome and Genective collaborate to create novel insect-resistant crops 2
... In biological research laboratories, filtration techniques are performed to ... buffers, and separate and purify samples for processing. In most cases, ... , The majority of filtration ... to 50 Torr (25 28Hg). A number of plastic ...
... , Overview: ... in analyzing the proteome of human serum is the dynamic range of ... (HSA) constitutes 57-71% of total serum protein and gammaimmunoglobulin (IgG) ranges from ... total protein present in serum, thereby allowing the enhanced detection of the ...
... Overview , ... has been used very little for quantitative studies. Analysts ... between analyte and internal standards and an inherent heterogeneity ... as a quantitative technique. In addition, conventional MALDI-TOF spectral ...
Cached Biology Technology: Improving the Efficiency of Common Filtration Tasks in your Laboratory 2 Improving the Efficiency of Common Filtration Tasks in your Laboratory 3Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 2Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 3Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 4Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 5Small-Molecule Quantitation Using Automated Single-Shot Averaging MALDI-TOF Mass Spectrometry 2Small-Molecule Quantitation Using Automated Single-Shot Averaging MALDI-TOF Mass Spectrometry 3
(Date:6/25/2015)...  TAKE Solutions Ltd., a global business technology solutions ... Patent and Trademark Office (USPTO) for its "Method for ... Clinical Accelerators to reduce the time taken to standardize ... without the accelerators), thus reducing time to market. ... the heart of the patented Clinical Data Standardization Process ...
(Date:6/24/2015)... , June 22, 2015 ... announced the addition of the "Huawei Ascend ... report to their offering. Huawei,s ... to the opposite direction than Apple,s and Samsung,s ... fingerprint sensor developed by Fingerprint Cards, a main ...
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... implications for improving fertilization in humans and other mammals, ... in red abalone, an ocean-dwelling snail, and made precise ... are the first scientists to do so. ... in the laboratory, the scientists were able to determine ...
... Calif., August 14, 2011 Newly diagnosed type 2 ... Exactly how diet and obesity trigger diabetes has long ... study led by Jamey D. Marth, Ph.D., director of ... of California, Santa Barbara and Sanford-Burnham Medical Research Institute ...
... VILNIUS, Lithuania, July 6, 2011 Neurotechnology ... today introduced VeriSpeak , the company,s new ... the VeriSpeak Software Development Kit (SDK) and as ... MegaMatcher 4.1 multi-biometric SDK, also announced today. VeriSpeak ...
Cached Biology News:UCLA life scientists' study of abalone yields new insights into sexual reproduction 2UCLA life scientists' study of abalone yields new insights into sexual reproduction 3UCLA life scientists' study of abalone yields new insights into sexual reproduction 4How fatty diets cause diabetes 2Neurotechnology Introduces VeriSpeak Voice Identification Technology 2Neurotechnology Introduces VeriSpeak Voice Identification Technology 3Neurotechnology Introduces VeriSpeak Voice Identification Technology 4